Evidence map›Paper›PMID 39877370›Full record

ArticleFrontiers in immunology2024

Transcriptional signature of CD56

Md Abdullah Al Kamran Khan, Alexander James Sedgwick, Yuhan Sun, Julian P Vivian, Alexandra J Corbett, Riccardo Dolcetti, Theo Mantamadiotis, Stefano Mangiola, Alexander David Barrow

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Frontiers in immunology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Article
  2. Review
  3. ZNF683Nature communications · 2026
    Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Md Abdullah Al Kamran KhanDepartment of Microbiology and Immunology, The University of Melbourne at The Peter Doherty Institute for Infection and Immunity, Melbourne, VIC, Australia.
Alexander James SedgwickDepartment of Microbiology and Immunology, The University of Melbourne at The Peter Doherty Institute for Infection and Immunity, Melbourne, VIC, Australia.
Yuhan SunDepartment of Microbiology and Immunology, The University of Melbourne at The Peter Doherty Institute for Infection and Immunity, Melbourne, VIC, Australia.
Julian P VivianSt. Vincent's Institute of Medical Research, Melbourne, VIC, Australia.
Alexandra J CorbettDepartment of Microbiology and Immunology, The University of Melbourne at The Peter Doherty Institute for Infection and Immunity, Melbourne, VIC, Australia.
Riccardo DolcettiDepartment of Microbiology and Immunology, The University of Melbourne at The Peter Doherty Institute for Infection and Immunity, Melbourne, VIC, Australia.
Theo MantamadiotisDepartment of Microbiology and Immunology, The University of Melbourne at The Peter Doherty Institute for Infection and Immunity, Melbourne, VIC, Australia.
Stefano MangiolaSouth Australian immunoGENomics Cancer Institute, The University of Adelaide, Adelaide, SA, Australia.
Alexander David BarrowDepartment of Microbiology and Immunology, The University of Melbourne at The Peter Doherty Institute for Infection and Immunity, Melbourne, VIC, Australia.

Funding

Wellcome Trust
6 · The paper itself

Abstract

Human natural killer (NK) cells can be sub-divided into two functional subsets but the clinical significance of these CD56

Indexed as

CD56 AntigenKiller Cells, NaturalTranscriptomeUrinary Bladder NeoplasmsBiomarkers, TumorCD8-Positive T-LymphocytesDendritic CellsGene Expression ProfilingGene Expression Regulation, NeoplasticHumansLymphocytes, Tumor-InfiltratingPrognosisTumor MicroenvironmentBiomarkers, TumorCD56 AntigenNCAM1 protein, humananti-tumour immunitybladder cancerCD56bright NKNK cellsprognosisTCGAtranscriptional signature

Identifiers

PMID39877370
PMCPMC11772185

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.